Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study.
van den Merkhof LF, Zijlstra F, Olsson H, Grip L, Veen G, Bär FW, van den Brand MJ, Simoons ML, Verheugt FW. van den Merkhof LF, et al. Among authors: verheugt fw. J Am Coll Cardiol. 1999 May;33(6):1528-32. doi: 10.1016/s0735-1097(99)00038-8. J Am Coll Cardiol. 1999. PMID: 10334418 Free article.
Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis.
Veen G, de Boer MJ, Zijlstra F, Verheugt FW. Veen G, et al. Among authors: verheugt fw. Am J Cardiol. 1999 Oct 1;84(7):763-7. doi: 10.1016/s0002-9149(99)00434-8. Am J Cardiol. 1999. PMID: 10513770
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Brouwer MA, van den Bergh PJ, Aengevaeren WR, Veen G, Luijten HE, Hertzberger DP, van Boven AJ, Vromans RP, Uijen GJ, Verheugt FW. Brouwer MA, et al. Among authors: verheugt fw. Circulation. 2002 Aug 6;106(6):659-65. doi: 10.1161/01.cir.0000024408.81821.32. Circulation. 2002. PMID: 12163424 Clinical Trial.
603 results